These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 19645627)

  • 1. Low prevalence and variable clinical presentation of troponin I and troponin T gene mutations in hypertrophic cardiomyopathy.
    Curila K; Benesova L; Penicka M; Minarik M; Zemanek D; Veselka J; Widimsky P; Gregor P
    Genet Test Mol Biomarkers; 2009 Oct; 13(5):647-50. PubMed ID: 19645627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac troponin I mutations in Australian families with hypertrophic cardiomyopathy: clinical, genetic and functional consequences.
    Doolan A; Tebo M; Ingles J; Nguyen L; Tsoutsman T; Lam L; Chiu C; Chung J; Weintraub RG; Semsarian C
    J Mol Cell Cardiol; 2005 Feb; 38(2):387-93. PubMed ID: 15698845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency and clinical expression of cardiac troponin I mutations in 748 consecutive families with hypertrophic cardiomyopathy.
    Mogensen J; Murphy RT; Kubo T; Bahl A; Moon JC; Klausen IC; Elliott PM; McKenna WJ
    J Am Coll Cardiol; 2004 Dec; 44(12):2315-25. PubMed ID: 15607392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals.
    Sedaghat-Hamedani F; Kayvanpour E; Tugrul OF; Lai A; Amr A; Haas J; Proctor T; Ehlermann P; Jensen K; Katus HA; Meder B
    Clin Res Cardiol; 2018 Jan; 107(1):30-41. PubMed ID: 28840316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and spectrum of mutations in the sarcomeric troponin T and I genes in a cohort of Spanish cardiac hypertrophy patients.
    García-Castro M; Reguero JR; Morís C; Alonso-Montes C; Berrazueta JR; Sainz R; Alvarez V; Coto E
    Int J Cardiol; 2007 Sep; 121(1):115-6. PubMed ID: 17101185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and Prognostic Profiles of Cardiomyopathies Caused by Mutations in the Troponin T Gene.
    Ripoll-Vera T; Gámez JM; Govea N; Gómez Y; Núñez J; Socías L; Escandell Á; Rosell J
    Rev Esp Cardiol (Engl Ed); 2016 Feb; 69(2):149-58. PubMed ID: 26507537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Studies of Hypertrophic Cardiomyopathy in Singaporeans Identify Variants in
    Pua CJ; Tham N; Chin CWL; Walsh R; Khor CC; Toepfer CN; Repetti GG; Garfinkel AC; Ewoldt JF; Cloonan P; Chen CS; Lim SQ; Cai J; Loo LY; Kong SC; Chiang CWK; Whiffin N; de Marvao A; Lio PM; Hii AA; Yang CX; Le TT; Bylstra Y; Lim WK; Teo JX; Padilha K; Silva GV; Pan B; Govind R; Buchan RJ; Barton PJR; Tan P; Foo R; Yip JWL; Wong RCC; Chan WX; Pereira AC; Tang HC; Jamuar SS; Ware JS; Seidman JG; Seidman CE; Cook SA
    Circ Genom Precis Med; 2020 Oct; 13(5):424-434. PubMed ID: 32815737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic diagnosis of hypertrophic cardiomyopathy using mass spectrometry DNA arrays and high resolution melting.
    Santos S; Lança V; Oliveira H; Branco P; Silveira L; Marques V; Brito D; Madeira H; Bicho M; Fernandes AR
    Rev Port Cardiol; 2011 Jan; 30(1):7-18. PubMed ID: 21425739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mutations in genes for sarcomeric proteins].
    Kimura A
    Nihon Rinsho; 2000 Jan; 58(1):117-22. PubMed ID: 10885298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lifelong Clinical Impact of the Presence of Sarcomere Gene Mutation in Japanese Patients With Hypertrophic Cardiomyopathy.
    Nakashima Y; Kubo T; Sugiura K; Ochi Y; Takahashi A; Baba Y; Hirota T; Yamasaki N; Kimura A; Doi YL; Kitaoka H
    Circ J; 2020 Sep; 84(10):1846-1853. PubMed ID: 32830170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives.
    Andersen PS; Havndrup O; Hougs L; Sørensen KM; Jensen M; Larsen LA; Hedley P; Thomsen AR; Moolman-Smook J; Christiansen M; Bundgaard H
    Hum Mutat; 2009 Mar; 30(3):363-70. PubMed ID: 19035361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic MYH7, MYBPC3, TPM1, TNNT2 and TNNI3 mutations in sporadic hypertrophic cardiomyopathy.
    Núñez L; Gimeno-Blanes JR; Rodríguez-García MI; Monserrat L; Zorio E; Coats C; McGregor CG; Hernandez del Rincón JP; Castro-Beiras A; Hermida-Prieto M
    Circ J; 2013; 77(9):2358-65. PubMed ID: 23782526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy.
    Girolami F; Olivotto I; Passerini I; Zachara E; Nistri S; Re F; Fantini S; Baldini K; Torricelli F; Cecchi F
    J Cardiovasc Med (Hagerstown); 2006 Aug; 7(8):601-7. PubMed ID: 16858239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genetic changes and clinical management in familial hypertrophic cardiomyopathy].
    Domal-Kwiatkowska D; Smolik S; Mazurek U; Moric E; Polońska J; Nowalany-Kozielska E; Glanowska G; Wodniecki J; Szarek J; Wilczewski P; Kozakiewicz K; Tendera M; Wilczok T
    Wiad Lek; 2000; 53(1-2):4-21. PubMed ID: 10806915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of Hypertrophic Cardiomyopathy Related Gene Mutations and Clinical Manifestations in Vietnamese Patients With Hypertrophic Cardiomyopathy.
    Tran Vu MT; Nguyen TV; Huynh NV; Nguyen Thai HT; Pham Nguyen V; Ho Huynh TD
    Circ J; 2019 Aug; 83(9):1908-1916. PubMed ID: 31308319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of Arginine to Glutamine substitution at 98, 141 and 162 positions in Troponin I (TNNI3) associated with hypertrophic cardiomyopathy among Indians.
    Rani DS; Nallari P; Priyamvada S; Narasimhan C; Singh L; Thangaraj K
    BMC Med Genet; 2012 Aug; 13():69. PubMed ID: 22876777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fabry disease among hypertrophic cardiomyopathy of genetic origin].
    Bouvagnet P; Millat G; Rousson R; Gilbert G; Derumeaux G
    Rev Med Interne; 2010 Dec; 31 Suppl 2():S233-7. PubMed ID: 21211671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features of hypertrophic cardiomyopathy caused by a Lys183 deletion mutation in the cardiac troponin I gene.
    Kokado H; Shimizu M; Yoshio H; Ino H; Okeie K; Emoto Y; Matsuyama T; Yamaguchi M; Yasuda T; Fujino N; Ito H; Mabuchi H
    Circulation; 2000 Aug; 102(6):663-9. PubMed ID: 10931807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy.
    Van Driest SL; Vasile VC; Ommen SR; Will ML; Tajik AJ; Gersh BJ; Ackerman MJ
    J Am Coll Cardiol; 2004 Nov; 44(9):1903-10. PubMed ID: 15519027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertrophic cardiomyopathy. A study of the troponin-T gene in 127 Spanish families.
    Gimeno JR; Monserrat L; Pérez-Sánchez I; Marín F; Caballero L; Hermida-Prieto M; Castro A; Valdés M
    Rev Esp Cardiol; 2009 Dec; 62(12):1473-7. PubMed ID: 20038417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.